Abstract:ObjectThe aim of this study was to test the feasibility of sentinel lymph node detection using contrast ultrasound imaging in normal subjects and patients with breast lesions.MethodsThirteen subjects including 2 normal subjects and 11 patients with breast masses were included this study. Ultrasound contrast agent SonoVue was injected subcutaneously into the upper quadrant of breast or adjacent mass at a total dose of 1-2 ml at a given location. Real time ultrasound with contrast imaging modes and high frequency probe (5-13 MHz) was used to image the region of the injection and axillary areas.ResultsA total of 17 injections was performed. One to ten minutes after contrast injection, hyperechogenic lymphatic channels were visualized in 13 cases and sentinel lymph nodes were enhanced progressively over time on grey-scale contrast imaging in 10 cases. The enhanced nodes appeared as either uniform or spoke-like enhancement pattern. In two normal subjects and one patient, lymphatic channel and node did not detect after two injections. Some lymphatic channels entered into deep tissue and cannot be traced to lymph node(s).ConclusionSonoVue-enhanced ultrasound imaging may be feasible to visualize breast lymphatic system which may play an important role for evaluation of breast tumor. ObjectThe aim of this study was to test the feasibility of sentinel lymph node detection using contrast ultrasound imaging in normal subjects and patients with breast lesions. The aim of this study was to test the feasibility of sentinel lymph node detection using contrast ultrasound imaging in normal subjects and patients with breast lesions. MethodsThirteen subjects including 2 normal subjects and 11 patients with breast masses were included this study. Ultrasound contrast agent SonoVue was injected subcutaneously into the upper quadrant of breast or adjacent mass at a total dose of 1-2 ml at a given location. Real time ultrasound with contrast imaging modes and high frequency probe (5-13 MHz) was used to image the region of the injection and axillary areas. Thirteen subjects including 2 normal subjects and 11 patients with breast masses were included this study. Ultrasound contrast agent SonoVue was injected subcutaneously into the upper quadrant of breast or adjacent mass at a total dose of 1-2 ml at a given location. Real time ultrasound with contrast imaging modes and high frequency probe (5-13 MHz) was used to image the region of the injection and axillary areas. ResultsA total of 17 injections was performed. One to ten minutes after contrast injection, hyperechogenic lymphatic channels were visualized in 13 cases and sentinel lymph nodes were enhanced progressively over time on grey-scale contrast imaging in 10 cases. The enhanced nodes appeared as either uniform or spoke-like enhancement pattern. In two normal subjects and one patient, lymphatic channel and node did not detect after two injections. Some lymphatic channels entered into deep tissue and cannot be traced to lymph node(s). A total of 17 injections was performed. One to ten minutes after contrast injection, hyperechogenic lymphatic channels were visualized in 13 cases and sentinel lymph nodes were enhanced progressively over time on grey-scale contrast imaging in 10 cases. The enhanced nodes appeared as either uniform or spoke-like enhancement pattern. In two normal subjects and one patient, lymphatic channel and node did not detect after two injections. Some lymphatic channels entered into deep tissue and cannot be traced to lymph node(s). ConclusionSonoVue-enhanced ultrasound imaging may be feasible to visualize breast lymphatic system which may play an important role for evaluation of breast tumor. SonoVue-enhanced ultrasound imaging may be feasible to visualize breast lymphatic system which may play an important role for evaluation of breast tumor.

Comparison of SonoVue and Sonazoid in Localization of Sentinel Lymph Nodes in Early Breast Cancer Patients

Experimental Study for Diagnosing Sentinel Lymph Nodes of Breast Cancer Using Real Time Contrast-Enhanced Ultra-Sound

Comparative Study of Two Contrast Agents for Intraoperative Identification of Sentinel Lymph Nodes in Patients with Early Breast Cancer

A Phase 3 Multicentre, Randomised, Comparative Study of the Efficacy and Safety of Sonazoid and SonoVue in Subjects with Focal Liver Lesions Undergoing Pre- and Post-Contrast Ultrasound Imaging

The Value of Contrast Enhanced Ultrasound in the Location of Sentinel Lymph Node in Breast Cancer

Percutaneous Sonazoid-enhanced Ultrasonography Combined with in Vitro Verification for Detection and Characterization of Sentinel Lymph Nodes in Early Breast Cancer

Proto-explore of Ultrasound Contrast Agents Injected Subcutaneously for Enhancement in Sentinel Lymph Nodes of Breast Masses

Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid

The value of contrast‐enhanced ultrasound in determining the location of sentinel lymph nodes in breast cancer

Comparison of Sonazoid and Sonovue in the Diagnosis of Focal Liver Lesions: A Preliminary Study.

Improved differential diagnosis of focal liver disease using SonoVue with nonlinear scanning mode

[Clinical Application of Sentinel Lymph Node Biopsy under the Guidance of Contrast-Enhanced Ultrasound Plus Methylene Blue in Patients with Breast Cancer].

Contrast-Enhanced Ultrasound With SonoVue and Sonazoid for the Diagnosis of Colorectal Liver Metastasis After Chemotherapy.

Value of contrast enhanced ultrasound to sentinel lymph node biopsy in breast cancer

0651: Contrast-Enhanced Ultrasound Imaging of Breast Sentinel Lymph Nodes: Preliminary Observation

Head-to-head Comparison of Sonazoid and SonoVue in the Diagnosis of Hepatocellular Carcinoma for Patients at High Risk

A Research on Contrast-enhanced Ultrasound and Detection of Human Mammaglobin Gene in Axilla Lymph Node of Breast Masses

The Application of Contrast-Enhanced Ultrasound for Sentinel Lymph Node Evaluation and Mapping in Breast Cancer Patients.

Compared with SonoVue ® LR-5, Sonazoid ® modified LR-5 has better diagnostic sensitivity for hepatocellular carcinoma: a systematic review and meta-analysis

Comparison of Sentinel Lymph Node Detection Performances Using Blue Dye in Conjunction with Indocyanine Green or Radioisotope in Breast Cancer Patients: a Prospective Single-Center Randomized Study

Comparison Between SonoVue and Sonazoid Contrast‐Enhanced Ultrasound in Characterization of Focal Nodular Hyperplasia Smaller Than 3 Cm